(Q40900121)

24 September 2017

1 reference

title

Antifungal agents in the 1990s. Current status and future developments (English)

1 reference

24 September 2017

Kauffman CA

1

1 reference

24 September 2017

Carver PL

series ordinal

2

1 reference

24 September 2017

language of work or name

1 reference

1 April 1997

1 reference

24 September 2017

1 reference

24 September 2017

53

1 reference

24 September 2017

539-549

1 reference

24 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753040-00001

24 September 2017

0 references

cites work

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

1 reference

12 December 2020

Old and new therapies for sporotrichosis

1 reference

12 December 2020

Candidal vulvovaginitis.

1 reference

12 December 2020

Treatment of cutaneous sporotrichosis with terbinafine.

1 reference

12 December 2020

In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373

1 reference

12 December 2020

Fluconazole-induced congenital anomalies in three infants

1 reference

12 December 2020

Oral azole drugs as systemic antifungal therapy

1 reference

12 December 2020

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

1 reference

12 December 2020

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

1 reference

12 December 2020

In vitro activity of BMS-181184 compared with those of fluconazole and amphotericin B against various candida spp

1 reference

12 December 2020

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Clearance of funguria with short-course antifungal regimens: a prospective, randomized, controlled study

1 reference

12 December 2020

Yeast in the urine: solutions for a budding problem

1 reference

12 December 2020

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

1 reference

12 December 2020

Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group

1 reference

12 December 2020

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

1 reference

12 December 2020

Resistance of Candida species to fluconazole

1 reference

12 December 2020

Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis

1 reference

12 December 2020

Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients

1 reference

12 December 2020

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

1 reference

12 December 2020

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

12 December 2020

Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Candida, infections in normal and immunosuppressed mice

1 reference

12 December 2020

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

1 reference

12 December 2020

MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

1 reference

12 December 2020

Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data

1 reference

12 December 2020

Antibiotics that inhibit fungal cell wall development

1 reference

12 December 2020

Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy

1 reference

12 December 2020

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

1 reference

12 December 2020

The pharmacokinetics of oral itraconazole in AIDS patients

1 reference

12 December 2020

Lipid formulations of amphotericin B: recent progress and future directions

1 reference

12 December 2020

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

1 reference

12 December 2020

Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays

1 reference

12 December 2020

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

12 December 2020

Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.

1 reference

12 December 2020

Chronic candidal meningitis: an uncommon manifestation of candidiasis

1 reference

12 December 2020

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

12 December 2020

Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS

1 reference

12 December 2020

Resistance of yeasts to azole-derivative antifungals

1 reference

12 December 2020

In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species

1 reference

12 December 2020

Use of liposomes as injectable-drug delivery systems

1 reference

12 December 2020

Mechanisms and clinical impact of antifungal drug resistance.

1 reference

12 December 2020

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

12 December 2020

Congenital malformations in an infant born to a woman treated with fluconazole

1 reference

12 December 2020

Itraconazole therapy in aspergillosis: study in 49 patients

1 reference

12 December 2020

Alternative modalities of administering amphotericin B: current issues

1 reference

12 December 2020

Antifungal susceptibility testing. Current state of technology, limitations, and standardization

1 reference

12 December 2020

Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma

1 reference

12 December 2020

Itraconazole therapy for chronic coccidioidal meningitis

1 reference

12 December 2020

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

1 reference

12 December 2020

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

12 December 2020

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial

1 reference

12 December 2020

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

12 December 2020

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

1 reference

12 December 2020

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

12 December 2020

Disseminated Fusarium solani infection

1 reference

12 December 2020

Amphotericin B intralipid formulation: stability and particle size.

1 reference

12 December 2020

Use of amphotericin B with azole antifungal drugs: what are we doing?

1 reference

12 December 2020

Is antifungal susceptibility testing useful in guiding fluconazole therapy?

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.

1 reference

12 December 2020

Systemic treatment of skin candidosis: a randomized comparison of terbinafine and ketoconazole

1 reference

12 December 2020

Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis

1 reference

12 December 2020

Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group

1 reference

12 December 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

12 December 2020

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

1 reference

12 December 2020

Itraconazole treatment of phaeohyphomycosis.

1 reference

12 December 2020

Compounds active against cell walls of medically important fungi

1 reference

12 December 2020

In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis

1 reference

12 December 2020

Low itraconazole serum concentrations following administration of itraconazole suspension to critically ill allogeneic bone marrow transplant recipients

1 reference

12 December 2020

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group

1 reference

12 December 2020

Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor

1 reference

12 December 2020

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

1 reference

12 December 2020

Fluconazole treatment of Candida albicans infection in mice: does in vitro susceptibility predict in vivo response?

1 reference

12 December 2020

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

12 December 2020

Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus

1 reference

12 December 2020

Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?

1 reference

12 December 2020

Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients

1 reference

12 December 2020

Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis

1 reference

12 December 2020

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

12 December 2020

Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group

1 reference

12 December 2020

Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice

1 reference

12 December 2020

Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia

1 reference

12 December 2020

Amphotericin B: 30 years of clinical experience

1 reference

12 December 2020

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

1 reference

12 December 2020

Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group

1 reference

12 December 2020

Role of azoles in antifungal therapy

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

Use of azoles for systemic antifungal therapy

1 reference

12 December 2020

A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group

1 reference

12 December 2020

Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias

1 reference

12 December 2020

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

1 reference

12 December 2020

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata

1 reference

12 December 2020

10.2165/00003495-199753040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference